Skip to main content
Figure 3 | BMC Neurology

Figure 3

From: Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study

Figure 3

Mean change in VAS diary pain score during full-dose treatment in the comparative phase (intent-to-treat population). The VAS ranged from 0 mm (no pain) to 100 mm (worst possible pain). The mean change was calculated from the mean of 21 full-dose injections for each patient. IFN, interferon; SD, standard deviation; VAS, visual analog scale.

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us